Traumatic Brain Injury (TBI) is known as the signature wound of the Iraq and Afghanistan wars and reports show that TBI's increase each year in the US Military. Vycor Medical, Inc. and NovaVision, Inc. present minimally invasive solutions for brain injuries - including a revolutionary neurosurgery device and vision restoration therapy for vision loss due to TBI.
BOCA RATON, FL, June 9, 2011 – In effort to update physicians, caregivers, and our service members dealing with Traumatic Brain Injury – the signature wound of the Iraq and Afghanistan wars, Vycor Medical, Inc. will present at the Military Healthcare Convention and Conference (MHCC) in San Antonio, TX on June 14th. Vycor Medical is the pioneer behind the minimally invasive ViewSite™ Brain Access System (VBAS) for deep-seated targets in neurosurgery and will introduce NovaVision’s non-invasive Vision Restoration Therapy™ (VRT). NovaVision is wholly owned by Vycor Medical.
According to the Department of Defense (DoD) the worldwide numbers for service members with traumatic brain injury (TBI) since 2000 has reached a total of 212,742 – already reporting 9,861 for 2011Q1. Some of the most common causes of TBI in the military include explosive devices, falls and vehicle or motorcycle accidents, Improvised Explosive Devices, or IEDs, used extensively against Coalition Forces. Results of TBI can vary; such injuries could require surgical removal of shrapnel and result in possible disabilities like vision loss. With statistics of traumatic brain injury (TBI) rising each year within the US military the VBAS minimally invasive surgical device and VRT may provide service members a better chance of regaining a normal life after rehabilitation.
The VBAS is an elliptical access device that allows surgeons to reach some of the deepest targets in the brain, including shrapnel. This access system utilizes a minimally invasive approach by spreading tissue as opposed to cutting it, which in return provides better patient outcome – the most valuable result postoperatively which could lead to reduced cost of care. Design advantages: made of clear plastic material that allows more accurate visualization of desired target and surrounding tissue; its low profile tubular design minimizes tissue damage when inserted into the brain while optimizing the work area. Peer Reviewed Studies: recently published in the Journal of Minimally Invasive Neurosurgery and Journal of Neurosurgery: Pediatrics, both of which report less tissue manipulation than with normal resection and several key advantages over the standard blade retractors currently being used for surgery. The VBAS has been used at VA hospitals in the US and was recently used for a case in New York to remove bullet fragments from a patient’s brain.
As more TBI’s occur, the number of patients with vision loss as a result will also increase – leaving our service members with a disability that may severely risk their independence and overall quality of life. NovaVision has developed an FDA cleared, non-invasive rehabilitation program, VRT, which expands a patient’s visual field from deficits including, hemianopia, scotoma, and quadranopia. These deficits can occur as a result from stroke, head trauma or other acquired brain injuries. Design Advantages: The patient performs the therapy on a home-device twice a day for 20-30 minutes a session. The results are evaluated and the therapy is adjusted as the patients progress each month. The patient typically performs the therapy for 6 months but can continue as long as their visual field continues to expand and consults with their physician. Peer Reviewed Studies: The therapy has been proven to be effective regardless of the patient’s age or the time from the damage causing the deficit. Nearly 3/4th‘s of patients receive a significant increase in their visual field. The vast majority of patients (88%) responding to a post therapy poll acknowledged significant improvements in their ability to perform daily activities, especially feeling safer in their mobility.
About Vycor Medical, Inc.
With corporate headquarters in Boca Raton, FL, Vycor Medical, Inc. (VYCO.BB) is a medical device company committed to making neurological brain, spinal and other surgical procedures safer and more effective. The company’s flagship, Patent Pending ViewSite™ Surgical Access Systems represent an exciting new minimally invasive access and retraction system that holds the potential for speedier, safer and more economical brain, spinal and other surgeries and a quicker patient discharge. Vycor’s innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. Vycor is ISO 13485:2003 compliant, has FDA 510(K) clearance for brain and spine surgeries, and CE marketing and HPB licensing in Canada.
Vycor Medical’s subsidiary NovaVision, Inc. researches, develops and provides science-driven light-based neurostimulation therapy and other medical technologies that help restore sight to patients with neurological vision impairments. The company’s proprietary, Visual Restoration Therapy (VRT) platform is FDA-cleared and clinically supported to improve lost vision resulting from stroke, brain cancer, traumatic brain injury (“TBI”), or other acquired brain injury. VRT can be prescribed by any ophthalmologist, optometrist, neurologist or physiatrist. NovaVision also provides a device that aids in the early identification of visual field deficits: the Head Mounted Perimeter (HMPTM) - a portable and ADA-compliant instrument to aid in the detection and measurement of visual field deficits even in bed-ridden patients. For the latest information on the company, including media and other coverage, and to learn more, please go online at www.VycorMedical.com or www.NovaVision.com.
Posts
No comments:
Post a Comment